1 Theophylline metabolism was studied using seven human cytochrome P-450 isoforms (CYPs), namely CYPlAl, 1A2, 2A6, 2B6, 2D6, 2E1 and 3A4, and microsomal epoxide hydroxylase (EH), expressed in human B-lymphoblastoid cell lines. 2 At a high theophylline concentration of 10 mm four CYPs (lAl, 1A2, 2D6, 2E1) catalyzed the metabolism of theophylline. 3 Theophylline had the highest affinity (apparent Km range 0.2-1.0 mM) for the CYPIA subfamily and the kinetics of metabolic formation mediated by CYP1A2
Introduction
It is well recognized that the metabolism of theoacid (DMU), 3-methylxanthine (3MX) and 1-methylphylline is influenced by many variables including uric acid (IMU) (Figure 1 ), and these metabolites are genetic factors [1] , smoking [2] [3] [4] , disease [5, 6] and eliminated predominantly by the kidneys. In human drugs [7] . In man theophylline is biotransformed urine unchanged drug, DMU, IMU and 3MX principally in the liver by the microsomal mixedrepresent 13, 48, 20 and 13%, respectively of the function oxide system (MFOi to 1,3-dimethyluric eliminated amount [8] [9] [10] . Among the primary metabolites, DMU is clearly the main product. 1- methylxanthine (IMX), which is formed primarily by 3-demethylation, is present in a high concentration in in vitro studies [11] [12] [13] but only represents 4.6% of the urinary recovery because in vivo it is rapidly converted to IMU by xanthine oxidase [8] . Indirect evidence suggests that theophylline is metabolized by more than one CYP, including CYP1A2 [11] [12] [13] [14] . Using a high substrate concentration (20 mM) Sarkar et al. [14] observed that CYPs 1A2 and 2E1, but not CYP3A3, contributed to theophylline metabolism in human microsomes. However, at such a high substrate concentration the authors were not able to distinguish the activities of high-and low-affinity CYPs involved in the reaction. Gu et al. [15] incubated theophylline (1 mM) with cDNA expressed human CYPs and found that CYPs 1A2, 2E1 and 3A4 contributed to its metabolism. Fuhr et al. [16] found exclusive metabolism of theophylline to DMU using cell lines expressing human CYP1A2. Thus, the qualitative and quantitative aspects of the involvement of various CYPs in the metabolism of theophylline are unclear.
The aims of the present study were to identify the CYP(s) involved in the metabolism of theophylline using microsomes prepared from human B-lymphoblastoid cell lines stably transfected with different human CYPs and epoxide hydroxylase, and to clarify their relative contributions to theophylline metabolism in vivo. 
Methods

Microsomal incubations
Theophylline (0.04-25 mM) in 0.1 M sodium phosphate buffer, pH 7.4 and an NADPH generating system (0.5 iu isocitrate dehydrogenase, 3 mM NADP, 5 mm sodium isocitrate and 5 mm MgCl2) were made up to a volume of 0.5 ml in 1.5 ml polypropylene tubes. After preincubation for 2 min at 370C, the reaction was started by addition of 0.25 mg microsomal protein previously maintained at 40C. After incubating at 370 C for 3 h under air, the reaction was stopped by addition of 0.050 ml 2M HCl and 7 ml dichloromethane:isopropyl alcohol (80:20 v/v). Internal standard (500 ng theobromine dissolved in water) and 0.5 g ammonium sulphate were added to the reaction mixture. The tube was capped and shaken for 10 min (Labshaker, Basel, Switzerland). After centrifugation at 1000 g for 5 min, the organic phase was transferred to a conical test tube and evaporated to dryness under nitrogen at 370 C. The residue was dissolved in 150 ,ul of mobile phase and 120 ,ul were injected onto the h.p.l.c. In experiments using recombinant CYP2A6, the phosphate buffer was replaced by Tris buffer 0.1 M pH 7.4, because phosphate buffer inhibits the activity of this CYP.
Enzyme kinetics were determined in duplicate incubations performed on the same day using nine theophylline concentrations (0.03 to 10 mM) for CYPlAl, nine concentrations (0.03 to 9 mM) for CYP1A2, nine concentrations (0.7 to [19] . Thus, the average specific contents of CYPs 1A2, 2E1, 2D6 were assumed to be 13, 7 and 2%, respectively, of total cytochrome P450.
Because the specific content of inducible CYPlAl is not known, it was set arbitrarily at 1%. Thus, the contribution of each individual CYP to the formation of a given metabolite can be estimated and expressed as a percentage of total formation.
Results
The limit of determination of all of the measured theophylline metabolites was 2 gM, and between-and within-day coefficients of variation of the assays were less than 5% in the concentration range 50-1000 ng ml-' and 8-14% for concentrations below 50 ng ml-'. The initial rate of theophylline metabolism was linear with microsomal protein concentration (10-100 ,ug) over 4 h. Therefore, 50 ,ug microsomal protein per assay and an incubation time of 3 h were used in all experiments. At a substrate concentration of 10 mM, CYPs lAl, 1A2, 2D6, and 2E1 catalyzed theophylline biotransformation to demethylated and 8-hydroxylated metabolites, whereas the production of metabolites in incubations containing CYPs 2A6, 2B6, microsomal epoxide hydroxylase or control cell microsomes containing only vector was below the assay detection limit. The CYP3A4 expression system was shown to metabolize caffeine and nimodipine, but did not show any significant activity with respect to theophylline metabolism.
The formation of theophylline metabolites by CYPs lAl, 2D6, 2E1 obeyed Michaelis-Menten enzyme kinetics, whereas metabolite formation mediated by CYP1A2 was better described by a substrateinhibition model [18] (Figure 2) . Estimates of the kinetic parameters and their standard deviation (s.d.) for each CYP are shown in Table 2 . The data show that theophylline has a particularly high affinity for the CYPlA subfamily. The apparent Km and Ki values were in the range of 0.2-1 and 7-14 mm, respectively. The apparent Km value for 3MX formation by CYP1A2 was somewhat greater than those for 1MX and DMU but was in the same range when the standard deviation of the estimates was considered. CYPlAl, which may be expressed extrahepatically [20] as well as in some human livers [21] , was also shown to catalyze the metabolism of theophylline, but only to 1MX. Furthermore, CYP2E1 was shown [22] (Gentest Co.'s code: CYP2D6-Met). The apparent Km values of the CYP2D6-mediated reactions were in the range of 7-8 mm and intrinsic formation clearance of the main metabolite DMU (60 ml h-1 mol-' CYP) was only about 3 and 22%, respectively, of that mediated by CYP1A2 and 2E1.
Using the data on relative abundance of human liver CYPs it was predicted that at theophylline concentrations below 0.1 mm (18 ,ug ml-), CYP1A2 is the most active isoform catalyzing theophylline by 8- ,-f i^X n -1.40x)ea hydroxylation, although, at higher substrate concentrations CYP2E1 may contribute (Figure 3a) . In contrast to 8-hydroxylation, 3-demethylation is predicted to be mediated almost exclusively by CYPlA over the substrate concentration range 0.01-40 mM (Figure 3b) . Thus, the data suggest that theophylline 1-demethylation is catalyzed in vivo specifically by CYP1A2 and that CYPlAl (when not induced) and CYP2D6 contribute to only a small extent.
Discussion
Among the eight CYPs tested, only CYP1A2 was found to catalyze all of the demethylations and hydroxylation of theophylline. This isoform was associated with the highest intrinsic clearance, in [19] . * 1A2, OL 2D6, 0 2E1, * lAl.
Theophyine 4mM)
In vitro theophylline metabolism 325 particular for the formation of the major metabolite DMU and may, therefore, be considered as the main CYP involved in theophylline metabolism. As proposed by Sarkar et al. [14] , CYPlAl may also metabolize theophylline in human liver microsomes, but the participation of this isoform in their studies was difficult to evaluate because the amount of CYPlAl in human liver is small. In the present study, CYPlAl only weakly catalyzed the N3-demethylation of theophylline to 1MX. It has been shown that the content of CYPlAl varies widely in human liver [21] and it may be expressed extrahepatically, especially in the lung [20] . However, it is possible that isoforms other than CYPlAl are involved in theophylline metabolism in the lung, because human lung microsomes convert theophylline exclusively to DMU [23] . An increase in the urinary recovery of theophylline metabolites in the urine of smokers is consistent with the inducibility of CYPlAl isoforms by tobacco smoke [24] . Our data reveal also that the substrate dependent formation kinetics of theophylline metabolites mediated by CYP1A2 in vitro may be better described by substrate-inhibition enzyme kinetics than by classical Michaelis-Menten kinetics. In man theophylline elimination kinetics are also non-linear [11, 12] . Therefore, it is possible that the substrate-inhibition phenomenon may also occur in vivo.
Previous investigations have shown that cigarette smoking induces CYP1A2 [25] and influences theophylline demethylation to a greater extent than hydroxylation [2] [3] [4] . Therefore, it is possible that more than one CYP isoform contributes to theophylline metabolism in man. Sarkar et al. [14] and Gu et al. [15] showed that CYPs 1A2 and 2E1 may metabolize theophylline in vitro. With its relatively high apparent Km value, CYP2E1 may act as the lowaffinity enzyme observed previously in in vitro studies [8, [13] [14] [15] .
Our data may clarify some aspects of drug interactions with theophylline. Cimetidine [26] , mexiletine [27] , propranolol [28] and ciprofloxacin [29] inhibit the demethylation of theophylline to a greater extent than its hydroxylation, and the converse is true for disulfiram [30] . The differential effects on theophylline pathways may be explained. If CYP2E1 contributes to hydroxylation of theophylline as a low-affinity high-capacity enzyme in vivo the 30% decrease in theophylline clearance observed by Loi et al. [30] in the presence of disulfiram is understandable. This hypothesis is supported by our in vitro data, since the contribution of CYP2E1 to DMU formation is predicted to begin to increase in the therapeutic range of plasma concentrations (5 and 20 jg ml-or 0.03-0.11 mM) [31] . Furthermore, since CYP2E1 is induced by chronic ethanol intake [32] [33] [34] , our data would predict the increase in theophylline clearance observed in alcoholics by Jusko et al. [35] . This is of particular relevance, as up to 50% of alcoholics have evidence of chronic obstructive pulmonary disease [36] and require theophylline therapy.
The comparison of apparent intrinsic clearance values suggests that the contribution of CYP2D6 to theophylline metabolism in vivo is of little importance.
With regard to the role of CYP3A4 in theophylline metabolism, Gu et al. [15] have reported that theophylline hydroxylation is also mediated by this isoform and its activity was about 20% of that of CYP1A2 and 2E1. However, in the present study, although the CYP3A4 expression system was capable of metabolizing caffeine and nimodipine, it did not show any significant activity with respect to theophylline. This observation is in agreement with Sarkar's data [14] .
In summary, our studies confirm that at least four CYPs participate in human theophylline metabolism. They confirm also the dominant role of CYP1A2, with CYP2E1 acting as a low-affinity, high-capacity isoform contributing to the production of the main theophylline metabolite DMU.
